Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Brendan James Mulhern

TitleFaculty Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Whitehurst DGT, Brazier JE, Viney R, Mulhern BJ. The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D? Pharmacoeconomics. 2020 Dec; 38(12):1283-1288. PMID: 32909144.
      View in: PubMed
    2. Howard K, Anderson K, Cunningham J, Cass A, Ratcliffe J, Whop LJ, Dickson M, Viney R, Mulhern B, Tong A, Garvey G. What Matters 2 Adults: a study protocol to develop a new preference-based wellbeing measure with Aboriginal and Torres Strait Islander adults (WM2Adults). BMC Public Health. 2020 Nov 17; 20(1):1739. PMID: 33203391.
      View in: PubMed
    3. Hettiarachchi R, Kularatna S, Byrnes J, Mulhern B, Chen G, Scuffham PA. Valuation study for a preference-based quality of life measure for dental caries (Dental Caries Utility Index - DCUI) among Australian adolescents - study protocol. BMJ Open. 2020 Oct 21; 10(10):e038626. PMID: 33087374.
      View in: PubMed
    4. Comans TA, Nguyen KH, Ratcliffe J, Rowen D, Mulhern B. Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff. Pharmacoeconomics. 2020 08; 38(8):871-881. PMID: 32314315.
      View in: PubMed
    5. Marten O, Mulhern B, Bansback N, Tsuchiya A. Implausible States: Prevalence of EQ-5D-5L States in the General Population and Its Effect on Health State Valuation. Med Decis Making. 2020 08; 40(6):735-745. PMID: 32696728.
      View in: PubMed
    6. Engel L, Bucholc J, Mihalopoulos C, Mulhern B, Ratcliffe J, Yates M, Hanna L. A qualitative exploration of the content and face validity of preference-based measures within the context of dementia. Health Qual Life Outcomes. 2020 Jun 11; 18(1):178. PMID: 32527264.
      View in: PubMed
    7. Campbell JA, Jelinek GA, Weiland TJ, Nag N, Neate SL, Palmer AJ, Mulhern B, De Livera A, Simpson-Yap S. SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis. Qual Life Res. 2020 Sep; 29(9):2509-2527. PMID: 32488685.
      View in: PubMed
    8. Brazier JE, Mulhern BJ, Bjorner JB, Gandek B, Rowen D, Alonso J, Vilagut G, Ware JE. Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2. Med Care. 2020 06; 58(6):557-565. PMID: 32412942.
      View in: PubMed
    9. Mulhern BJ, Bansback N, Norman R, Brazier J. Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration. Med Care. 2020 06; 58(6):566-573. PMID: 32221100.
      View in: PubMed
    10. van Hout B, Mulhern B, Feng Y, Shah K, Devlin N. The EQ-5D-5L Value Set for England: Response to the "Quality Assurance". Value Health. 2020 05; 23(5):649-655. PMID: 32389231.
      View in: PubMed
    11. Pearce AM, Mulhern BJ, Watson V, Viney RC. How Are Debriefing Questions Used in Health Discrete Choice Experiments? An Online Survey. Value Health. 2020 03; 23(3):289-293. PMID: 32197722.
      View in: PubMed
    12. Franklin M, Mukuria C, Mulhern B, Tran I, Brazier J, Watson S. Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity. Patient. 2019 08; 12(4):405-417. PMID: 30820841.
      View in: PubMed
    13. Tsuchiya A, Bansback N, Hole AR, Mulhern B. Manipulating the 5 Dimensions of the EuroQol Instrument: The Effects on Self-Reporting Actual Health and Valuing Hypothetical Health States. Med Decis Making. 2019 05; 39(4):379-392. PMID: 31161860.
      View in: PubMed
    14. Norman R, Craig BM, Hansen P, Jonker MF, Rose J, Street DJ, Mulhern B. Issues in the Design of Discrete Choice Experiments. Patient. 2019 06; 12(3):281-285. PMID: 30446958.
      View in: PubMed
    15. Mulhern B, Norman R, De Abreu Lourenco R, Malley J, Street D, Viney R. Investigating the relative value of health and social care related quality of life using a discrete choice experiment. Soc Sci Med. 2019 07; 233:28-37. PMID: 31153085.
      View in: PubMed
    16. Mulhern B, Norman R, Street DJ, Viney R. One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. Pharmacoeconomics. 2019 01; 37(1):29-43. PMID: 30194624.
      View in: PubMed
    17. Bull C, Byrnes J, Mulhern B. We Respect Their Autonomy and Dignity, But How Do We Value Patient-Reported Experiences? MDM Policy Pract. 2018 Jul-Dec; 3(2):2381468318807458. PMID: 30450411.
      View in: PubMed
    18. Kreimeier S, Oppe M, Ramos-Goñi JM, Cole A, Devlin N, Herdman M, Mulhern B, Shah KK, Stolk E, Rivero-Arias O, Greiner W. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective. Value Health. 2018 11; 21(11):1291-1298. PMID: 30442276.
      View in: PubMed
    19. Tonmukayakul U, Le LK, Mudiyanselage SB, Engel L, Bucholc J, Mulhern B, Carter R, Mihalopoulos C. A systematic review of utility values in children with cerebral palsy. Qual Life Res. 2019 Jan; 28(1):1-12. PMID: 30073470.
      View in: PubMed
    20. Devlin NJ, Shah KK, Mulhern BJ, Pantiri K, van Hout B. A new method for valuing health: directly eliciting personal utility functions. Eur J Health Econ. 2019 Mar; 20(2):257-270. PMID: 30030647.
      View in: PubMed
    21. Rowen D, Labeit A, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H, Brazier J. Estimating a Preference-Based Single Index Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Med Decis Making. 2018 08; 38(6):699-707. PMID: 29957107.
      View in: PubMed
    22. Mulhern B, Feng Y, Shah K, Janssen MF, Herdman M, van Hout B, Devlin N. Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets. Pharmacoeconomics. 2018 06; 36(6):699-713. PMID: 29476363.
      View in: PubMed
    23. Mulhern B, Feng Y, Shah K, Janssen MF, Herdman M, van Hout B, Devlin N. Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets. Pharmacoeconomics. 2018 06; 36(6):727. PMID: 29679315.
      View in: PubMed
    24. Wong CKH, Mulhern B, Cheng GHL, Lam CLK. SF-6D population norms for the Hong Kong Chinese general population. Qual Life Res. 2018 Sep; 27(9):2349-2359. PMID: 29797176.
      View in: PubMed
    25. Rowen D, Mulhern B, Stevens K, Vermaire JH. Estimating a Dutch Value Set for the Pediatric Preference-Based CHU9D Using a Discrete Choice Experiment with Duration. Value Health. 2018 10; 21(10):1234-1242. PMID: 30314625.
      View in: PubMed
    26. Comans TA, Nguyen KH, Mulhern B, Corlis M, Li L, Welch A, Kurrle SE, Rowen D, Moyle W, Kularatna S, Ratcliffe J. Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol. BMJ Open. 2018 01 21; 8(1):e018996. PMID: 29358437.
      View in: PubMed
    27. Shah KK, Mulhern B, Longworth L, Janssen MF. Views of the UK General Public on Important Aspects of Health Not Captured by EQ-5D. Patient. 2017 Dec; 10(6):701-709. PMID: 28409481.
      View in: PubMed
    28. Mulhern B, Norman R, Shah K, Bansback N, Longworth L, Viney R. How Should Discrete Choice Experiments with Duration Choice Sets Be Presented for the Valuation of Health States? Med Decis Making. 2018 04; 38(3):306-318. PMID: 29084472.
      View in: PubMed
    29. Rowen D, Stevens K, Labeit A, Elliott J, Mulhern B, Carlton J, Basarir H, Ratcliffe J, Brazier J. Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Value Health. 2018 01; 21(1):69-77. PMID: 29304943.
      View in: PubMed
    30. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2018 01; 27(1):7-22. PMID: 28833869.
      View in: PubMed
    31. Feng Y, Devlin NJ, Shah KK, Mulhern B, van Hout B. New methods for modelling EQ-5D-5L value sets: An application to English data. Health Econ. 2018 01; 27(1):23-38. PMID: 28833854.
      View in: PubMed
    32. Stolk EA, Craig BM, Mulhern B, Brown DS. Health Valuation: Demonstrating the Value of Health and Lifespan. Patient. 2017 08; 10(4):515-517. PMID: 28597376.
      View in: PubMed
    33. Cole A, Shah K, Mulhern B, Feng Y, Devlin N. Valuing EQ-5D-5L health states 'in context' using a discrete choice experiment. Eur J Health Econ. 2018 May; 19(4):595-605. PMID: 28569351.
      View in: PubMed
    34. Mulhern B, Norman R, Lorgelly P, Lancsar E, Ratcliffe J, Brazier J, Viney R. Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration? Pharmacoeconomics. 2017 Apr; 35(4):439-451. PMID: 27873226.
      View in: PubMed
    35. Nguyen KH, Mulhern B, Kularatna S, Byrnes J, Moyle W, Comans T. Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D. Health Qual Life Outcomes. 2017 Jan 25; 15(1):21. PMID: 28122626.
      View in: PubMed
    36. Mulhern B, Bansback N, Hole AR, Tsuchiya A. Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences. Med Decis Making. 2017 04; 37(3):285-297. PMID: 27681988.
      View in: PubMed
    37. Norman R, Mulhern B, Viney R. The Impact of Different DCE-Based Approaches When Anchoring Utility Scores. Pharmacoeconomics. 2016 08; 34(8):805-14. PMID: 27034244.
      View in: PubMed
    38. Mulhern B, Pink J, Rowen D, Borghs S, Butt T, Hughes D, Marson A, Brazier J. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D. Value Health. 2017 Apr; 20(4):687-693. PMID: 28408012.
      View in: PubMed
    39. Mulhern B, Shah K, Janssen MF, Longworth L, Ibbotson R. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values? Value Health. 2016 Mar-Apr; 19(2):210-7. PMID: 27021755.
      View in: PubMed
    40. Shah K, Mulhern B, Longworth L, Janssen MF. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies. Value Health. 2016 Jan; 19(1):53-9. PMID: 26797236.
      View in: PubMed
    41. Mulhern B, O'Gorman H, Rotherham N, Brazier J. Comparing the measurement equivalence of EQ-5D-5L across different modes of administration. Health Qual Life Outcomes. 2015 Nov 26; 13:191. PMID: 26612336.
      View in: PubMed
    42. Palfreyman S, Mulhern B. The psychometric performance of generic preference-based measures for patients with pressure ulcers. Health Qual Life Outcomes. 2015 Aug 01; 13:117. PMID: 26231179.
      View in: PubMed
    43. Rowen D, Mulhern B, Banerjee S, Tait R, Watchurst C, Smith SC, Young TA, Knapp M, Brazier JE. Comparison of general population, patient, and carer utility values for dementia health states. Med Decis Making. 2015 01; 35(1):68-80. PMID: 25385749.
      View in: PubMed
    44. Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry. 2014 Sep; 205(3):236-43. PMID: 24855127.
      View in: PubMed
    45. Bansback N, Hole AR, Mulhern B, Tsuchiya A. Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues. Soc Sci Med. 2014 Aug; 114:38-48. PMID: 24908173.
      View in: PubMed
    46. Mulhern B, Rowen D, Snape D, Jacoby A, Marson T, Hughes D, Baker G, Brazier J. Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population. Epilepsy Behav. 2014 Jul; 36:12-7. PMID: 24836527.
      View in: PubMed
    47. Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Jones ML, Paisley S, O'Cathain A, Barkham M, Knapp M, Byford S, Gilbody S, Parry G. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014 May; 18(34):vii-viii, xiii-xxv, 1-188. PMID: 24857402.
      View in: PubMed
    48. Mulhern B, Meadows K. The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes. Health Qual Life Outcomes. 2014 Mar 24; 12:42. PMID: 24661350.
      View in: PubMed
    49. Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L, Rowen D, Tsuchiya A. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Health Technol Assess. 2014 Feb; 18(12):vii-xxvi, 1-191. PMID: 24568945.
      View in: PubMed
    50. Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P, Devianee Keetharuth A, Brazier J. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014 Feb; 18(9):1-224. PMID: 24524660.
      View in: PubMed
    51. Wong CK, Mulhern B, Wan YF, Lam CL. Responsiveness was similar between direct and mapped SF-6D in colorectal cancer patients who declined. J Clin Epidemiol. 2014 Feb; 67(2):219-27. PMID: 24189090.
      View in: PubMed
    52. Tyson JY, Pearce MM, Vargas P, Bagchi S, Mulhern BJ, Cianciotto NP. Multiple Legionella pneumophila Type II secretion substrates, including a novel protein, contribute to differential infection of the amoebae Acanthamoeba castellanii, Hartmannella vermiformis, and Naegleria lovaniensis. Infect Immun. 2013 May; 81(5):1399-410. PMID: 23429532.
      View in: PubMed
    53. Mulhern B, Longworth L, Brazier J, Rowen D, Bansback N, Devlin N, Tsuchiya A. Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPI. Value Health. 2013 Jan-Feb; 16(1):104-13. PMID: 23337221.
      View in: PubMed
    54. Glekas GD, Mulhern BJ, Kroc A, Duelfer KA, Lei V, Rao CV, Ordal GW. The Bacillus subtilis chemoreceptor McpC senses multiple ligands using two discrete mechanisms. J Biol Chem. 2012 Nov 16; 287(47):39412-8. PMID: 23038252.
      View in: PubMed
    55. Wong CK, Lam CL, Mulhern B, Law WL, Poon JT, Kwong DL, Tsang J. Measurement invariance of the Functional Assessment of Cancer Therapy-Colorectal quality-of-life instrument among modes of administration. Qual Life Res. 2013 Aug; 22(6):1415-26. PMID: 23054490.
      View in: PubMed
    56. Mulhern B, Rowen D, Jacoby A, Marson T, Snape D, Hughes D, Latimer N, Baker GA, Brazier JE. The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy Behav. 2012 May; 24(1):36-43. PMID: 22503427.
      View in: PubMed
    57. Rowen D, Mulhern B, Banerjee S, Hout Bv, Young TA, Knapp M, Smith SC, Lamping DL, Brazier JE. Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health. 2012 Mar-Apr; 15(2):346-56. PMID: 22433767.
      View in: PubMed
    58. Chatfield CH, Mulhern BJ, Viswanathan VK, Cianciotto NP. The major facilitator superfamily-type protein LbtC promotes the utilization of the legiobactin siderophore by Legionella pneumophila. Microbiology (Reading). 2012 Mar; 158(Pt 3):721-735. PMID: 22160401.
      View in: PubMed
    59. Mulhern B, Smith SC, Rowen D, Brazier JE, Knapp M, Lamping DL, Loftus V, Young TA, Howard RJ, Banerjee S. Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis. Value Health. 2012 Mar-Apr; 15(2):323-33. PMID: 22433764.
      View in: PubMed
    60. Chatfield CH, Mulhern BJ, Burnside DM, Cianciotto NP. Legionella pneumophila LbtU acts as a novel, TonB-independent receptor for the legiobactin siderophore. J Bacteriol. 2011 Apr; 193(7):1563-75. PMID: 21278293.
      View in: PubMed
    Mulhern's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)